At the time of writing, GeneDx Holdings Corp [WGS] stock is trading at $91.1, up 1.69%. An important factor to consider is whether the stock is rising or falling in short-term value. The WGS shares have gain 35.97% over the last week, with a monthly amount glided 30.11%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on May 15, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $88. Previously, Jefferies upgraded its rating to Buy on May 09, 2025, and kept the price target unchanged to $80. On August 28, 2024, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $34 on the stock. Craig Hallum started tracking the stock assigning a Buy rating and suggested a price target of $43 on July 10, 2024.
For the past year, the stock price of GeneDx Holdings Corp fluctuated between $24.91 and $117.75. Currently, Wall Street analysts expect the stock to reach $42.5 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $91.1 at the most recent close of the market. An investor can expect a potential drop of -53.35% based on the average WGS price forecast.
Analyzing the WGS fundamentals
According to GeneDx Holdings Corp [NASDAQ:WGS], the company’s sales were 330.14M for trailing twelve months, which represents an 39.56% jump. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.12%, and Net Profit Margin reading is -0.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.17 and Total Capital is -0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 88.51 points at the first support level, and at 85.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 93.42, and for the 2nd resistance point, it is at 95.74.
Ratios To Look Out For
It is important to note that GeneDx Holdings Corp [NASDAQ:WGS] has a current ratio of 3.25. On the other hand, the Quick Ratio is 3.07, and the Cash Ratio is 1.43. Considering the valuation of this stock, the price to sales ratio is 7.87, the price to book ratio is 10.10.
Transactions by insiders
Recent insider trading involved Stueland Katherine, Chief Executive Officer, that happened on Jun 16 ’25 when 10501.0 shares were sold. CHIEF FINANCIAL OFFICER, Feeley Kevin completed a deal on Jun 16 ’25 to sell 3729.0 shares. Meanwhile, CHIEF FINANCIAL OFFICER Feeley Kevin sold 1266.0 shares on Jun 09 ’25.
